Asia

Regional trend analysis, forecasts and market intelligence for the Pharma & Healthcare industry

Latest Asia Analysis

Industry Trend Analysis - Failure To Ratify TPP To Be A Loss For Innovative Pharmaceutical Firms - MAR 2017

A failure to ratify the Trans-Pacific Partnership (TPP) will be a negative for multinational drugmakers operating in the Asia Pacific. With seven of the 12 participating members in the APAC region, collectively accounting for 42% of the region's medicine sales in 2016, the trade deal would have altered the landscape by introducing stronger intellectual property protection among other measures. ...

READ FULL ARTICLE...

Industry Trend Analysis - Pharmaceutical Sales To Face Downside Risks From Demonetisation Policy - FEB 2017

India's demonetisation policy will accentuate the operational risks facing pharmaceutical firms operating in the country. Risks for the sector will be acute in the short term as the ban on large-denomination currency notes imposes payment barriers to patients in a market that is heavily reliant on out-of-pocket spending. The policy's full impact is expected to be more pronounced in the next few...

READ FULL ARTICLE...